List of SBIR/STTR awards granted to Myolex Inc
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Myolex Inc in September, 2019 for $621,318.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 9R44NS113756-02 | Phase II | 621,318 | September 1, 2019 | |||||||
A SBIR Phase II contract was awarded to Myolex Inc in September, 2021 for $697,807.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AR079336-01A1 | Phase II | 697,807 | September 17, 2021 | |||||||
A SBIR Phase II contract was awarded to Myolex Inc in September, 2018 for $1,494,842.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44NS070385-05 | Phase II | 1,494,842 | September 1, 2018 | |||||||
A SBIR Phase I contract was awarded to Myolex Inc in September, 2018 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AR074805-01 | Phase I | 225,000 | September 11, 2018 | |||||||
A STTR Phase I contract was awarded to Myolex Inc in September, 2018 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41AR074345-01 | Phase I | 225,000 | September 20, 2018 | |||||||
A SBIR Phase II contract was awarded to Myolex Inc in August, 2022 for $889,385.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AG074840-01A1 | Phase II | 889,385 | August 1, 2022 | |||||||
A SBIR Phase I contract was awarded to Myolex Inc in September, 2017 for $149,998.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AR073114-01 | Phase I | 149,998 | September 20, 2017 | |||||||
A SBIR Phase II contract was awarded to Myolex Inc in May, 2014 for $1,510,396.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44NS073188-03 | Phase II | 1,510,396 | May 1, 2014 | |||||||
A SBIR Phase I contract was awarded to Myolex Inc in January, 2011 for $149,956.0 USD from the National Science Foundation. | SBIR | 1046826 | Phase I | 149,956 | January 1, 2011 | |||||||
A SBIR Phase I contract was awarded to Myolex Inc for $220,621.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43NS070385-01 | Phase I | 220,621 | ||||||||
A SBIR Phase II contract was awarded to Myolex Inc for $1,101,745.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AR064142-02 | Phase II | 1,101,745 | ||||||||
A SBIR Phase II contract was awarded to Myolex Inc for $1,691,143.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44NS070385-02A1 | Phase II | 1,691,143 | ||||||||
A STTR Phase I contract was awarded to Myolex Inc for $225,000.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AG047021-01 | Phase I | 225,000 | ||||||||
A SBIR Phase I contract was awarded to Myolex Inc for $289,901.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43NS073188-01A1 | Phase I | 289,901 |
